The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, foundations, government, not for profit organizations, non-governmental organizations, the private sector, military and private practice.
Keynote Address
Decolonizing science to benefit all: Reflections of an African researcher on the frontlines
Date: Wednesday, 13 November 2024
Time: 17:30 – 19:00
Room: Convention Center – Hall J (1st floor)
Speaker: Monique Wasunna, Africa Ambassador, DNDi
Watch the recording:
Symposia
The path towards a treatment for dengue: Endemic country leadership, progress, and perspectives
Date: Friday, 15 November 2024
Time: 10:15 – 12:00
Room: Convention Center – Room 395/396 (3rd floor)
Moderators: Isabela Ribeiro, Viral Diseases Cluster Director, DNDi and André Siqueira, Head of Dengue Global Programme, DNDi
Speakers:
- Vivian Costa, Universidade Federal de Minas Gerais, Brazil
- Anna Vicco, Imperial College London, UK
- Richa Chandra, Novartis, India
- Steven Lim, Raja Permaisuri Bainun Hospital, Malaysia
Advancing research to improve treatment of neglected tropical diseases in children
Date: Friday, 15 November 2024
Time: 13:45 – 15:30
Room: Convention Center – Room 388/389 (3rd floor)
Moderator: María-Jesús Pinazo, Head of Chagas Disease, DNDi
Speakers:
- Anthony Solomon, WHO, Switzerland
- Jaime Altcheh, Paediatrician and Parasitologist, Ricardo Gutierrez Children’s Hospital
- Saschveen Singh, Tropical Infectious Disease Advisor, Médecins Sans Frontières USA
- Borna Nyaoke, Head of Mycetoma Disease, DNDi
- Peter Steinmann, Head of the Diseases and Programmes Unit, Swiss TPH
- Olaf Valverde, Clinical Project Leader (HAT), DNDi
Advances in Chagas disease diagnostic assays and testing strategies
Date: Saturday, 16 November 2024
Time: 12:45 – 14:30
Room: Convention Center – Room 395/396 (3rd floor)
Moderator: Daniel Bourque, Boston Medical Centre
Speakers:
- María-Jesús Pinazo, Head of Chagas Disease, DNDi
- Jeffrey Whitman, University of California
- Alejandro Schijman, CONICET
Will HAT be the next NTD to achieve global elimination?
Date: Sunday, 17 November 2024
Time: 11:30 – 13:15
Room: Convention Center – Room 357 (3rd floor)
Moderators: Emily Crowley, University of Warwick and Rachel Bronzan, Gates Foundation
Speakers:
- Gerardo Priotto, WHO
- Erick Mwamba Miaka, National Sleeping Sickness Programme, Democratic Republic of the Congo
- Iñaki Tirados, Liverpool School of Tropical Medicine
- Stéphane Hugonnet, NTD HAT-Filarial-Chagas Cluster Director, DNDi
- Kat S. Rock, University of Warwick
Scientific session
Date: Sunday, 17 November 2024
Time: 8:00 – 9:45
Room: Convention Center – Room 352 (3rd floor)
| Efficacy and safety of thermotherapy in combination with miltefosine in comparison to miltefosine monotherapy for the treatment of cutaneous leishmaniasis in the Americas: A phase III, open label, multicenter, randomized trial Byron Arana, Head of Cutaneous Leishmaniasis Disease, DNDi Authors: Arana B, Pascale JM, Llanos-Cuentas A, Hueb M, Machado P, Soto J, Cota G, Rode J, Blum B, Boni M |
Posters
Date: Thursday, 14 November 2024
Time: 8:15
| The role of lipids as potential biomarkers of disease progression and therapeutic response in patients with chronic T. cruzi infection Gabaldón-Figueira JC, Ros-Lucas A, Martínez-Peinado N, Blackburn G, Losada-Galván I, Posada E, Ballart C, Escabia E, Capellades J, Yanes O, Pinazo MJ, Gascón J, Alonso-Padilla J |
Date: Thursday, 14 November 2024
Time: 12:00 – 13:45
Room: Convention Center – Hall I-1 (1st floor)
| Characterizing dengue seroprevalence and heterogeneities in transmission intensity in Ghana Afum-Adjei Awuah A*, Vicco A, Asamoah Adu E, Ebenezer Boham E, Alani H, Pomaah Wiredu A, Adu-Amoah L, Pedrique B, Guillerm M, Obirikorang C, Struck NS, Ribeiro I, Amuasi JH, Dorigatti I |
Date: Friday, 15 November 2024
Time: 12:00 – 13:45
Room: Convention Center – Hall I-1 (1st floor)
| Dengue seroprevalence and force of infection in the Democratic Republic of the Congo Nkuba-Ndaye A*, Vicco A, Mputu-Ngoyi B, Tshiminyi-Munkamba P, Baketana-Kinzonzi L, Matungulu-Biyala E, Nkawa F, Pedrique B, Guillerm M, Ribeiro I, Makiala-Mandanada S, Ahuka-Mundeke S, Dorigatti I |
| Development of alternative treatments for filarial diseases Specht S* |
Date: Saturday, 16 November 2024
Time: 11:00 – 12:45
Room: Convention Center – Hall I-1 (1st floor)
| Fexinidazole in patients with human African trypanosomiasis due to trypanosoma brucei rhodesiense, towards an arsenic-free, first-line therapy Valverde O*, Tizgo Nyirenda W, Eriatu A, Lemerani M, Wamboga C, Baudin E, Alves D, Matovu E |
| Seroprevalence of dengue in Senegal Gaye A, Vicco A*, Dieng I, Dia M, Ndiaye O, Ndiaye N, Mendy FW, Thiam MD, Pedrique B, Guillerm M, Shrivastava S, Ribeiro I, Loucoubar C, Talla C, Faye O, Dorigatti I |
| Adaptive basket trial to assess the efficacy and safety of oxfendazole as pan-nematode candidate in onchocerciasis, loiasis, mansonellosis and trichuriasis patients Hübner MP, Zehetmayer S, Keiser J, Mombo-Ngoma G, Mumba Ngoyi D, Ramharter M, Wanji S, Bofill Roig M, Lotola Mougeni F, Schnoz AS, Zoleko Manego R, Badjina L, Lenz B, Kazakov A, Scandale I, Monnot F, Hoerauf A, Posch M, Specht S* |
| Factors associated with relapse in visceral leishmaniasis: An individual patient data meta-analysis using the Infectious Diseases Data Observatory Data Platform Dahal P, Kumar R, Singh-Phulgenda S, Munir A, Ali Siddiqui N, Wilson J, Buck G, Naylor C, Brack M, Rahi M, Malaviya P, Wasunna M, Chappuis F, Ritmeijer K, Costa C, Romero G, Syriopoulou V, Musa A, Alves F, Stepniewska K, Guerin PJ, Pandey K |
Date: Sunday, 16 November 2024
Time: 9:30
| Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development del Mar Castro M, Erber AC, Arana B, Cota G, Denkinger C, Harrison N, Kutyi J, López-Carvajal L, Plugge E, Walochnik J, Olliaro P |
